- Recommendation ID
- NG144/8
- Question
What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment for adults with persistent nausea or vomiting not caused by chemotherapy which hasn't fully responded to optimised conventional antiemetics?
- Any explanatory notes
(if applicable)
Source guidance details
- Comes from guidance
- Cannabis-based medicinal products
- Number
- NG144
- Date issued
- November 2019
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 30/11/2019 |